Pfizer wins Swiss case for anti-smoking meds

, Comments 0 comments LAUSANNE, SWITZERLAND - US pharmaceutical company Pfizer won the Swiss Federal Tribunal’s backing Thursday 4 August for health insurers to cover the cost of Champix, a drug used by some smokers to ease their tobacco addiction. The court agreed that in some cases the addiction is an illness and the cost of the drug should [...]

0 Comments To This Article